McKesson Corporation $MCK Shares Sold by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC cut its holdings in shares of McKesson Corporation (NYSE:MCK) by 1.1% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 181,793 shares of the company’s stock after selling 1,960 shares during the quarter. Wealth Enhancement Advisory Services LLC owned approximately 0.15% of McKesson worth $150,255,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. GGM Financials LLC bought a new stake in shares of McKesson in the third quarter worth $25,000. State of Wyoming acquired a new position in McKesson during the 2nd quarter worth $29,000. Hopwood Financial Services Inc. bought a new stake in shares of McKesson in the 3rd quarter worth about $31,000. Vermillion & White Wealth Management Group LLC acquired a new stake in shares of McKesson in the 3rd quarter valued at about $33,000. Finally, Board of the Pension Protection Fund acquired a new stake in shares of McKesson in the 4th quarter valued at about $33,000. 85.07% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at McKesson

In other McKesson news, EVP Michele Lau sold 2,725 shares of McKesson stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $990.00, for a total transaction of $2,697,750.00. Following the sale, the executive vice president owned 3,247 shares of the company’s stock, valued at $3,214,530. The trade was a 45.63% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Thomas L. Rodgers sold 276 shares of the stock in a transaction on Monday, January 5th. The stock was sold at an average price of $816.18, for a total value of $225,265.68. Following the completion of the transaction, the executive vice president directly owned 2,268 shares of the company’s stock, valued at approximately $1,851,096.24. The trade was a 10.85% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 3,868 shares of company stock worth $3,743,820 over the last quarter. Insiders own 0.08% of the company’s stock.

Analysts Set New Price Targets

MCK has been the subject of a number of research reports. Robert W. Baird set a $968.00 price target on McKesson in a research note on Wednesday, January 14th. Mizuho increased their target price on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a report on Thursday, February 5th. Weiss Ratings lowered McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday, February 5th. Raymond James Financial set a $970.00 price target on McKesson in a report on Thursday, March 5th. Finally, Zacks Research cut McKesson from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 25th. Thirteen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $960.93.

McKesson Stock Performance

McKesson stock opened at $888.28 on Friday. The firm has a market capitalization of $108.81 billion, a P/E ratio of 25.55, a P/E/G ratio of 1.43 and a beta of 0.38. The company has a 50-day simple moving average of $903.68 and a 200-day simple moving average of $833.49. McKesson Corporation has a one year low of $637.00 and a one year high of $999.00.

McKesson (NYSE:MCK) last posted its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm had revenue of $106.16 billion during the quarter, compared to analyst estimates of $105.98 billion. During the same period in the previous year, the business posted $8.03 EPS. McKesson’s revenue was up 11.4% on a year-over-year basis. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, sell-side analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be issued a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Monday, March 2nd. McKesson’s dividend payout ratio is 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.